Matthieu Faron , MD1; Maurice Cheugoua-Zanetsie , MSc1; Jayne Tierney, PhD2; Pierre Thirion, MD3; Matthew Nankivell , PhD2; Kathryn Winter, PhD4; Hong Yang , MD5; Joel Shapiro , MD6; Dewi Vernerey, PhD7; B. Mark Smithers, MD8; Thomas Walsh, MD9; Guillaume Piessen , MD10; Magnus Nilsson, MD11,12; Jurjen Boonstra , MD13; Marc Ychou, MD14; Simon Law, MD15; David Cunningham , MD16; Florent de Vathaire , PhD1; Michael Stahl, MD17; Susan Urba, MD18; Michele Valmasoni , MD19; Danièle Williaume, MD20; Janine Thomas, MD21; Florian Lordick, MD22; Joel Tepper , MD23; Jack Roth, MD24; Val Gebski , PhD25; Bryan Burmeister, PhD21; Xavier Paoletti , PhD26; Johanna van Sandick, MD27; Jianhua Fu , MD5; Jean-Pierre Pignon , MD1; Michel Ducreux, MD28; and Stefan Michiels , PhD1; on behalf of the MANATEC-02 Collaborative Group
Read Abstract: Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
.png){kind=logo}
